Case Studies
 Noven
- Noven, a specialty neuro pharma company, engaged Sage to assist it in a buyside transaction
- Objectives were specified as increasing revenue, requirement for an expanded sales infrastructure and enhanced product pipeline in the neuro space
- Sage assembled an initial long shortlist and honed this down to 6 candidates in conjunction with Noven’s Board
- Negotiations with one candidate proceeded apace and a deal valued at $125M for the acquisition of JDS Pharma was closed within four months
|
 Return to all case studies
|